Allogene Therapeutics, Inc. (ALLO) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Allogene Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -1.58x | -1.61x | -1.54x | -2.64x | -11.13x | -12.14x |
| P/B Ratio | 1.03x | 0.98x | 0.98x | 1.35x | 2.19x | 2.81x |
| P/S Ratio | 0.00x | 18861.34x | 5302.65x | 5771.76x | 17.76x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 100.0% | 100.0% | -9063.5% | 100.0% | 0.0% |
| Operating Margin | 0.0% | -1241813.6% | -344986.3% | -215087.2% | -157.9% | 0.0% |
| Net Margin | 0.0% | -1170863.6% | -344489.5% | -218214.1% | -159.6% | 0.0% |
| EBITDA Margin | 0.0% | -1106031.8% | -329543.2% | -205923.7% | -148.8% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 7.93x | 8.54x | 12.38x | 9.84x | 9.84x | 8.96x |
| Quick Ratio | 7.93x | 8.54x | 12.38x | 9.84x | 9.84x | 8.96x |
| Leverage | ||||||
| Debt/Equity | 0.26x | 0.21x | 0.19x | 0.15x | 0.08x | 0.05x |
YoY = year-over-year change. Source: FMP..